Category Archives: Uncategorized

Q&A: Gauging Impact of Comparative Effectiveness Research

While at DIA’s 50th Annual Meeting, we got the chance to speak with Nancy Dreyer, chief of scientific affairs and senior VP at Quintiles Outcome, the CRO’s real-world and late-phase research division, about the current tide for comparative effectiveness research (CER). Dreyer is the leader of the GRACE Initiative, which has developed good practice principles for […]
Also posted in comparative effectiveness, Global, healthcare, Regulatory | Tagged , , , , , | Leave a comment

Clayton Christensen on the Future of Pharma

A keynote speaker at the 9thAnnual SaS Health Care & Life Sciences Executive Conference on May 10, ‘disruptive’ author of The Innovator’s Dilemma and Harvard business professor Clayton Christensen sat down with PharmExec to discuss the future of the pharmaceutical industry, and what Mitt Romney could bring to the White House.
Also posted in Biotech, Events, FDA, healthcare, IP, leadership, People, R&D, Regulatory, Safety, Technology | Tagged , , , , , , , , , , , , | 1 Comment

Allergan Offers to Pay Journos to Discuss Botox

Physicians aren’t the only ones getting paid to attend industry-sponsored events heavy on product discussions. For $250, “select” journalists can discuss facial aesthetics at an event sponsored by Botox-maker Allergan, on June 9 in New York City. Journalistic ethics can be checked at the door. The emailed invitation to attend Allergan’s Facial Aesthetics Advisory Panel, […]
Also posted in Events, Strategy | Tagged , , , | 1 Comment

Eliminate Waste (Whatever That Is)

There’s a fascinating editorial in this week’s New England Journal of Medicine by Henry J. Aaron, a healthcare economist at the Brookings Institution. Aaron argues that on average healtchare spending is not wasteful, since its benefits exceed its costs. But that doesn’t mean there isn’t waste. The trick, though, is to identify it, and as […]
Posted in Uncategorized | Tagged , , , | Leave a comment
  • Categories

  • Meta